Home > Journals > Minerva Biotechnology and Biomolecular Research > Aim and scope

CURRENT ISSUEMINERVA BIOTECHNOLOGY AND BIOMOLECULAR RESEARCH

A Journal on Biotechnology and Molecular Biology

Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SCIE), Scopus
Impact Factor 3.028

Quarterly

pISSN 2724-542X

eISSN 2724-5934

 

Aims and scope

Minerva Biotechnology and Biomolecular Research, a quarterly international, peer-reviewed scientific journal
of Biotechnology and Molecular Biology, indexed in EMBASE, Science Citation Index Expanded (SCIE), Scopus
has an impact factor of 3.028.
The journal publishes four issues of high-quality preclinical research articles (original articles, reviews, letters and
editorials) per annum.
Our aim is to continue to improve the positive trends of recent years and publish scientific articles of great interest
to basic researchers and clinical investigators.
The Journal offers a fast and rigorous peer review process as well as open access options.
Minerva Biotechnology and Biomolecular Research welcomes articles on a wide variety of molecular biotechnology
applications with special focus on: Regenerative Medicine, Cancer, Host-Pathogen interactions and Microbiota,
Biomarkers and biosensors, Drug Discovery, Immunology, Endocrinology, Metabolism, Bioinformatics.


Chief Editor
Sharmila Fagoonee
Institute of Biostructure and Bioimaging (CNR)
c/o Molecular Biotechnology Center, Turin, Italy

top of page